These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26486735)

  • 21. Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis.
    Carder PJ; Shaaban A; Alizadeh Y; Kumarasuwamy V; Liston JC; Sharma N
    Histopathology; 2010 Sep; 57(3):472-8. PubMed ID: 20727019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions.
    Goldstein NS; Bassi D; Watts JC; Layfield LJ; Yaziji H; Gown AM
    Am J Clin Pathol; 2001 Apr; 115(4):534-42. PubMed ID: 11293901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
    Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
    Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ.
    Downs-Kelly E; Bell D; Perkins GH; Sneige N; Middleton LP
    Arch Pathol Lab Med; 2011 Jun; 135(6):737-43. PubMed ID: 21631266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DCIS and LCIS with multinucleated giant cells-a report of 4 cases.
    Coyne JD
    Histopathology; 2007 Apr; 50(5):669-71. PubMed ID: 17394507
    [No Abstract]   [Full Text] [Related]  

  • 27. Is there a low-grade precursor pathway in breast cancer?
    King TA; Sakr RA; Muhsen S; Andrade VP; Giri D; Van Zee KJ; Morrow M
    Ann Surg Oncol; 2012 Apr; 19(4):1115-21. PubMed ID: 21935747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast.
    Desai AA; Jimenez RE; Hoskin TL; Day CN; Boughey JC; Hieken TJ
    Ann Surg Oncol; 2018 Oct; 25(10):3064-3068. PubMed ID: 29947004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity.
    Reis-Filho JS; Simpson PT; Jones C; Steele D; Mackay A; Iravani M; Fenwick K; Valgeirsson H; Lambros M; Ashworth A; Palacios J; Schmitt F; Lakhani SR
    J Pathol; 2005 Sep; 207(1):1-13. PubMed ID: 15957152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
    Rabban JT; Chen YY
    Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.
    Mahoney MC; Robinson-Smith TM; Shaughnessy EA
    AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mixed pleomorphic lobular and apocrine carcinoma of the breast: A case report suggesting pathogenesis.
    Ishii A; Oishi T; Kakuda Y; Yasui H; Kawata T; Muramatsu K; Takahashi K; Sugino T
    Pathol Int; 2019 May; 69(5):288-293. PubMed ID: 30811750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases.
    Khoury T; Karabakhtsian RG; Mattson D; Yan L; Syriac S; Habib F; Liu S; Desouki MM
    Histopathology; 2014 Jun; 64(7):981-93. PubMed ID: 24372322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin.
    Dabbs DJ; Bhargava R; Chivukula M
    Am J Surg Pathol; 2007 Mar; 31(3):427-37. PubMed ID: 17325485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Noninvasive breast carcinomas: anatomicopathological, diagnostic and therapeutic findings].
    Calabrese L
    Acta Biomed Ateneo Parmense; 1998; 69(3-4):113-21. PubMed ID: 10503071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of immunohistochemistry in the diagnosis of problematic breast lesions.
    Lee AH
    J Clin Pathol; 2013 Jun; 66(6):471-7. PubMed ID: 23486609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pleomorphic Lobular Carcinoma in Situ Diagnosed by Breast Core Biopsy: Clinicopathologic Features and Correlation With Subsequent Excision.
    Guo T; Wang Y; Shapiro N; Fineberg S
    Clin Breast Cancer; 2018 Aug; 18(4):e449-e454. PubMed ID: 29102711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.
    Fadare O; Dadmanesh F; Alvarado-Cabrero I; Snyder R; Stephen Mitchell J; Tot T; Wang SA; Ghofrani M; Eusebi V; Martel M; Tavassoli FA
    Am J Surg Pathol; 2006 Nov; 30(11):1445-53. PubMed ID: 17063087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.